What is CRISPR and how will it impact me? According to one myeloma expert, the biggest pre-ASH “buzz” this year centered around abstract 49: “First-In-Human Assessment of Feasibility and Safety of Multiplexed Genetic Engineering of Autologous T Cells Expressing NY-ESO-1 TCR and CRISPR/CAS9 Gene Edited to Eliminate Endogenous TCR and PD-1b(NYCE T cells) in Advanced [...]
This post first appeared on Page Not Found - The Myeloma Crowd, please read the originial post: here
